Indivior: failure to disclose 2017 UK transfers of value on ABPI central platform (AUTH/3138/12/18)

📅 2018 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/3138/12/18
PartiesEx-employee v Indivior
IssueNon-disclosure of transfers of value
Applicable Code year2016
Complaint received20 December 2018
Case completed19 August 2019
AppealNo appeal
Breach clauses2; 9.1; 24.1; 24.4
No breach clauses24.6
Core findingFailure to publicly disclose 2017 UK transfers of value on the ABPI central platform by end of June 2018 (required due to listed non-member status from June 2017).
Sanctions appliedUndertaking received; Additional sanctions; Advertisement

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An ex-employee alleged Indivior did not disclose 2017 payments to health professionals, donations or sponsorships in the UK (and referenced missing historic website disclosures).
  • Indivior said it had documented transfers of value (ToVs) for 2015 onwards, but disclosure was the issue rather than collection/monitoring.
  • Indivior stated it was unaware that, from June 2017, a previous senior employee had agreed the company would become a listed non-member company, comply with the Code and accept PMCPA jurisdiction.
  • Because of that lack of internal awareness, Indivior did not disclose 2017 UK ToVs on the ABPI central platform by the end of June 2018 (as required for its status from June 2017).
  • Indivior removed its voluntarily disclosed 2015 UK ToV data (and methodological note) from its website in March 2018 while seeking to improve its disclosure page.
⚖️

Outcome

  • Breach of Clauses 24.1 and 24.4 for failure to disclose 2017 UK ToVs on the central platform by the required deadline.
  • No breach of Clause 24.6 (data retention) for 2017 ToV records.
  • Breach of Clause 9.1 (high standards).
  • Breach of Clause 2 (bringing discredit upon and reducing confidence in the industry) due to lack of transparency/public disclosure.
  • No ruling on Clauses 24.5 and 24.10 because, as there had been no public disclosure at the time the complaint was received, the Panel considered them not relevant.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training